Thomas Schirrmann Selected Research

T-Cell Lymphoma (Lymphoma, T Cell)

1/2012

Human antibodies targeting CD30(+) lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Schirrmann Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 04/2002
3	Infections 11/2021 - 01/2011
3	Lymphoma (Lymphomas) 04/2014 - 04/2008
2	Communicable Diseases (Infectious Diseases) 01/2021 - 02/2009
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 10/2016
2	COVID-19 01/2021 - 01/2021
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2014 - 01/2012
2	Inflammation (Inflammations) 01/2013 - 01/2012
1	Tetanus 01/2021
1	Diphtheria 01/2021
1	Chronic Disease (Chronic Diseases) 10/2016
1	Adenocarcinoma 09/2016
1	Pathologic Processes 01/2016
1	Confusion (Bewilderment) 01/2016
1	Human Influenza (Influenza) 11/2015
1	Hodgkin Disease (Hodgkin's Disease) 04/2014
1	Hematologic Neoplasms (Hematological Malignancy) 04/2014
1	Paralysis (Palsy) 03/2014
1	Bacterial Infections (Bacterial Infection) 01/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2012
1	Neuroblastoma 01/2012
1	Carcinoma (Carcinomatosis) 01/2011
1	Pneumonia (Pneumonitis) 09/2008
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2005

Drug/Important Bio-Agent (IBA)

12	AntibodiesIBA 01/2021 - 01/2009
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2008
3	Neutralizing AntibodiesIBA 11/2021 - 05/2014
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2011
3	Monoclonal AntibodiesIBA 10/2016 - 01/2012
3	Immunoglobulins (Immunoglobulin)IBA 03/2014 - 04/2002
2	Pancreatic Ribonuclease (Ribonuclease A)IBA 01/2018 - 03/2014
2	AntigensIBA 01/2018 - 03/2014
2	Ribonucleases (Ribonuclease)IBA 01/2018 - 04/2008
2	Peptides (Polypeptides)IBA 01/2012 - 09/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2005 - 04/2002
1	Immunoglobulin FragmentsIBA 01/2021
1	Recombinant DNA (Recombinant DNA Research)IBA 10/2016
1	Cyclin-Dependent Kinase 4IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Inosine Monophosphate (IMP)IBA 11/2015
1	HLA-A*02:01 antigenIBA 11/2015
1	Immunotoxins (Immunotoxin)IBA 04/2014
1	Brentuximab VedotinIBA 04/2014
1	Immunoconjugates (Immunoconjugate)IBA 04/2014
1	incobotulinumtoxinA FDA Link 03/2014
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	C-Reactive ProteinIBA 01/2013
1	Ki-1 AntigenIBA 01/2012
1	Neoplasm AntibodiesIBA 01/2010
1	scleroglucanIBA 02/2009
1	Carcinoembryonic AntigenIBA 04/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2010
4	Immunotherapy 01/2015 - 04/2002
2	Drug Therapy (Chemotherapy) 04/2014 - 01/2012
1	Radiotherapy 04/2014
1	Lasers (Laser) 01/2012